France
xRapid Group is a visionary biotechnology company headquartered in France, founded in 2015 by Jean Viry-Babel and Prof. David Mendels. Driven by the slogan "Pushing the boundaries of Artificial Intelligence in diagnostics," the company applies cutting-edge AI and computer vision technologies to address global health challenges. Initially focusing on diagnostics for malaria in resource-limited areas, they achieved notable success and earned approval from the World Health Organization, impacting lives in countries like Benin, Indonesia, and Uganda.
In a strategic pivot enabled by William Young in 2016, xRapid Environment was founded to develop commercial applications for environmental testing. The company now leverages deep learning to automate the analysis of asbestos fibers and mold spores, demonstrating robust technological capabilities across multiple sectors, including Biotechnology, Health Care, and Mobile. The last funding milestone was a Series A investment on 1 September 2016, marking a critical financial juncture to support its dual focus on philanthropic and commercial growth paths.
